Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improvement of ovarian cortex survival by supplementation of growth hormone in freezing media
TCTR20170324002Phase 1Recruiting
- Sponsor
- The Factory of Medicine
- Start
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of somatropin in fertility preservation (2 arms), sponsored by The Factory of Medicine. Primary endpoint: Ovarian cortex tissue survival after freezing. Started Mar 2017; status: recruiting.
02
Drugs
somatropin
03
Conditions
fertility preservation
Beyond the preview
Go deeper on TCTR20170324002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170324002.